Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype

Arthritis and Rheumatism
Silvia S PierangeliJane E Salmon

Abstract

Patients with the antiphospholipid antibody syndrome (APS) often experience recurrent arterial and venous thrombosis and pregnancy losses. Intravenous immunoglobulin (IVIG) therapy has prevented pregnancy loss in some women with APS and has reversed fetal resorption rates in murine models of pregnancy loss. Although the basis for these effects is unknown, effector mechanisms of pathogenic antibodies often involve receptors for IgG (Fc gamma receptors [Fc gammaR]). We examined the potential mechanisms of action of WIG in an in vivo murine model of antiphospholipid antibody (aPL)-induced thrombosis and endothelial cell activation. Mice infused with IgG containing human anticardiolipin antibodies (aCL) were treated with IVIG (36 microg i.v.), saline, or ovalbumin. Surgically induced thrombus formation and in vivo leukocyte adhesion to endothelial cells were measured. Circulating levels of aCL were measured by enzyme-linked immunosorbent assay. To determine whether Fc gammaR are required for the effects of IVIG, we treated mice deficient in stimulatory Fc gammaR. To examine the effects of IVIG on endogenously generated antibody, we treated mice immunized with beta2-glycoprotein I (beta2GPI). IVIG treatment inhibited aPL-induced end...Continue Reading

References

Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M BlankY Shoenfeld
Jan 1, 1990·British Journal of Haematology·E N Harris
Oct 1, 1988·Annals of the Rheumatic Diseases·M A KhamashtaG R Hughes
Oct 1, 1987·British Journal of Rheumatology·E N Harris
May 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·R B Reinhold, J Fine
Jan 1, 1984·The International Journal of Biochemistry·H Wurm
Nov 1, 1995·The Journal of Clinical Investigation·R SimantovR L Silverstein
Jan 1, 1994·Springer Seminars in Immunopathology·E N Harris, S S Pierangeli
Dec 1, 1994·American Journal of Reproductive Immunology : AJRI·C B Coulam
Feb 1, 1995·American Journal of Obstetrics and Gynecology·J A SpinnatoE N Harris
Jan 1, 1994·Springer Seminars in Immunopathology·A Rifai
Oct 1, 1993·Clinical Immunology and Immunopathology·R BakimerY Shoenfeld
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·R P Junghans, C L Anderson
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·T OleeP P Chen
Oct 1, 1996·Lupus·S S Pierangeli, E N Harris
Aug 29, 1997·The Journal of Experimental Medicine·Z LiuC L Anderson
Jan 13, 1998·Immunology Today·V Ghetie, E S Ward
Jan 23, 1999·The New England Journal of Medicine·Z Yu, V A Lennon
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·M C KarlssonB Heyman
Jun 17, 1999·Clinical Obstetrics and Gynecology·A L Clark
Oct 16, 1999·La Revue de médecine interne·O BlétryA M Piette
Oct 21, 1999·The Journal of Surgical Research·X LiuG L Anderson

❮ Previous
Next ❯

Citations

Feb 6, 2002·Springer Seminars in Immunopathology·L RauovaY Shoenfeld
May 5, 2004·The Journal of Clinical Investigation·Shreeram AkileshDerry Roopenian
Nov 15, 2005·The Journal of Clinical Investigation·Ning LiZhi Liu
May 21, 2008·Lupus·J E Salmon, P G de Groot
Aug 8, 2002·Kidney International·Chike M NzerueE Nigel Harris
Oct 28, 2004·Thrombosis Research·Elizabeth M Benson
Oct 16, 2004·Lupus·G TrioloG Licata
Apr 26, 2006·Lupus·Ch López-PedreraM J Cuadrado
May 2, 2007·Nature Clinical Practice. Rheumatology·Jagadeesh BayrySrini V Kaveri
Sep 10, 2002·Current Rheumatology Reports·Ana I Quintero-Del-Rio
Mar 3, 2009·Nature Clinical Practice. Rheumatology·Doruk Erkan, Michael D Lockshin
May 11, 2011·Nature Reviews. Rheumatology·Jagadeesh BayrySrini V Kaveri
May 1, 2002·Current Opinion in Rheumatology·Robert A S Roubey
Sep 22, 2018·Drugs·Kyle T AmberMichael Hertl
Sep 23, 2020·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Massimo RadinSavino Sciascia
Jul 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Spiros MiyakisSteven A Krilis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.